Session Abstract – PMWC 2026 Silicon Valley
Track Chair: Alex Zhavoronkov, Insilico Medicine
PMWC Award Ceremony Honorees
• Steve Horvath, UCLA
• David Sinclair, Harvard
• Nir Barzilai, Albert Einstein College of Medicine
AI & Biomarkers for Measuring Aging
• Chair: Alex Zhavoronkov, Insilico Medicine
• Luigi Ferrucci, NIH
• Sara Hägg, Karolinska Institutet
• Daniel Belsky, Columbia
Epigenetic Rejuvenation & Delivery for Clinical Translation
• Ryan (Yuancheng) Lu, Whitehead Institute / MIT
• David Sinclair, Harvard
Clinical Trial Design & Functional Endpoints for Healthspan
• Nir Barzilai, Albert Einstein
Precision Aging & Longevity Focused on Limited Lifespan Evidence, Vanishing Blue Zones, and Payer ROI
• S. Jay Olshansky, University of Illinois
Speaker Profile
Ph.D., CEO, Insilico Medicine
Biography
Alex Zhavoronkov, PhD, is the founder and CEO of Insilico Medicine, a leading clinical-stage biotechnology company developing next-generation generative artificial intelligence and robotics platforms for drug discovery. Under his leadership, Insilico raised over $400 million in multiple rounds from expert biotechnology, healthcare, and financial investors, opened RD centers in 6 countries and regions, and partnered with multiple pharmaceutical, biotechnology, and academic institutions. Since 2021, the company nominated 21 preclinical candidates, started 6 human clinical trials, and entered Phase II with an AI-discovered novel target and AI-designed novel molecule. Since 2012, he has published over 200 peer-reviewed research papers and 3 books. He is the adjunct professor of artificial intelligence at the Buck Institute for Research on Aging.
Wellness & Aging Showcase:
Insilico Medicine
Insilico Medicine, a global clinical stage biotechnology company powered by generative AI, is connecting biology, chemistry, medicine and science research using next-generation AI systems.
Speaker Profile
Ph.D., Professor, Karolinska Inst.t
Biography
Associate professor in molecular epidemiology at the Department of Medical Epidemiology and Biostatistics at Karolinska Institutet and my research is about aging. I use data from the Swedish Twin Registry and the UK Biobank to look at biological aging and associations with age-related diseases.
Speaker Profile
M.D., Ph.D., Senior Investigator, NIH-NIA
Biography
Dr. Luigi Ferrucci is a geriatrician and an epidemiologist who conducts research on the causal pathways leading to progressive physical and cognitive decline in older persons. In September 2002, he became the Chief of the Longitudinal Studies Section at NIA and the Director of the Baltimore Longitudinal Study on Aging. Medical Degree and Board Certification in 1980, Board Certification in Geriatrics in 1982 and Ph.D. in Biology and Pathophysiology of Aging in 1998 at the University of Florence, Italy. Principal Investigator of the InCHIANTI study and of the Baltimore Longitudinal Study on Aging. Dr. Ferrucci is Scientific Director, NIA since May 2011.
